Heart valve market in Australia to reach $50m in 2030: report | Healthcare Asia Magazine
, Australia

Heart valve market in Australia to reach $50m in 2030: report

This is due to the rise of cardiovascular disease risks.

As the geriatric population in Australia practise an unhealthy lifestyle, GlobalData, global analytics firm, said the heart valve market will grow to $50m in 2030, driven by increasing cardiovascular diseases risks.

In a report, the increasing burden of cardiovascular disease will help grow the demand for minimally invasive processes.

GlobalData identified severe aortic stenosis is one of the most common aortic valve diseases with a gradual blockage due to calcium build-up, thereby narrowing and even blocking the aortic valve. 

With these factors, GlobalData sees that Australia’s prosthetic heart valve market, which is close to 8% of APAC market in 2023 is expected to grow at a compound annual growth rate (CAGR) of nearly 4% through 2030.

Ayshi Ganguly, medical devices analyst at GlobalData, said when primary treatment options for SAS do not respond for patients, valve replacement surgeries will be the alternative.

“However, post-implantation, these patients remain at a high risk of strokes and heart attacks,” added Ganguly.

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!